Literature DB >> 22326830

Psychosine induces the dephosphorylation of neurofilaments by deregulation of PP1 and PP2A phosphatases.

Ludovico Cantuti-Castelvetri1, Hongling Zhu, Maria I Givogri, Robstein L Chidavaenzi, Aurora Lopez-Rosas, Ernesto R Bongarzone.   

Abstract

Patients with Krabbe disease, a genetic demyelinating syndrome caused by deficiency of galactosyl-ceramidase and the resulting accumulation of galactosyl-sphingolipids, develop signs of a dying-back axonopathy compounded by a deficiency of large-caliber axons. Here, we show that axonal caliber in Twitcher mice, an animal model for Krabbe disease, is impaired in peripheral axons and is accompanied by a progressive reduction in the abundance and phosphorylation of the three neurofilament (NF) subunits. These changes correlate with an increase in the density of NFs per cross-sectional area in numerous mutant peripheral axons and abnormal increases in the activity of two serine/threonine phosphatases (PP1 and PP2A) in mutant tissue. Similarly, acutely isolated mutant cortical neurons show abnormal phosphorylation of NFs. Psychosine, the neurotoxin accumulated in Krabbe disease, was sufficient to induce abnormal dephosphorylation of NF subunits in a normal motor neuron cell line as well as in acutely isolated normal cortical neurons. This in vitro effect was mediated by PP1 and PP2A, which specifically dephosphorylated NFs. These results demonstrate that the reduced caliber observed in some axons in Krabbe disease involves abnormal dephosphorylation of NFs. We propose that a psychosine-driven pathogenic mechanism through deregulated phosphotransferase activities may be involved in this process.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326830      PMCID: PMC3323754          DOI: 10.1016/j.nbd.2012.01.013

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  76 in total

1.  Bidirectional translocation of neurofilaments along microtubules mediated in part by dynein/dynactin.

Authors:  J V Shah; L A Flanagan; P A Janmey; J F Leterrier
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Modulation of repulsive forces between neurofilaments by sidearm phosphorylation.

Authors:  Sanjay Kumar; Jan H Hoh
Journal:  Biochem Biophys Res Commun       Date:  2004-11-12       Impact factor: 3.575

Review 3.  From promiscuity to precision: protein phosphatases get a makeover.

Authors:  David M Virshup; Shirish Shenolikar
Journal:  Mol Cell       Date:  2009-03-13       Impact factor: 17.970

4.  Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments.

Authors:  Q Zhu; S Couillard-Després; J P Julien
Journal:  Exp Neurol       Date:  1997-11       Impact factor: 5.330

5.  Conditionally Immortalized Neural Cell Lines: Potential Models for the Study of Neural Cell Function

Authors: 
Journal:  Methods       Date:  1996-12       Impact factor: 3.608

6.  [Globoid cell leucodystrophy (Krabbe's disease). Peripheral nerve lesion (author's transl)].

Authors:  J J Martin; C Ceuterick; L Martin; J G Leroy; J P Nuyts; C Joris
Journal:  Acta Neurol Belg       Date:  1974 Nov-Dec       Impact factor: 2.396

Review 7.  Protein phosphatase 2A: variety of forms and diversity of functions.

Authors:  K Lechward; O S Awotunde; W Swiatek; G Muszyńska
Journal:  Acta Biochim Pol       Date:  2001       Impact factor: 2.149

8.  Axonal growth and guidance defects in Frizzled3 knock-out mice: a comparison of diffusion tensor magnetic resonance imaging, neurofilament staining, and genetically directed cell labeling.

Authors:  Yanshu Wang; Jiangyang Zhang; Susumu Mori; Jeremy Nathans
Journal:  J Neurosci       Date:  2006-01-11       Impact factor: 6.167

Review 9.  The inherited leukodystrophies: a clinical overview.

Authors:  J Aicardi
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

10.  Defects in sensory axon growth precede neuronal death in Brn3a-deficient mice.

Authors:  S R Eng; K Gratwick; J M Rhee; N Fedtsova; L Gan; E E Turner
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

View more
  27 in total

Review 1.  Clinical neurogenetics: neuropathic lysosomal storage disorders.

Authors:  Gregory M Pastores; Gustavo H B Maegawa
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Fluid levity of the cell: Role of membrane lipid architecture in genetic sphingolipidoses.

Authors:  Ludovic D'Auria; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

4.  Mechanism of neuromuscular dysfunction in Krabbe disease.

Authors:  Ludovico Cantuti-Castelvetri; Erick Maravilla; Michael Marshall; Tammy Tamayo; Ludovic D'auria; John Monge; James Jeffries; Tuba Sural-Fehr; Aurora Lopez-Rosas; Guannan Li; Kelly Garcia; Richard van Breemen; Charles Vite; Jesus Garcia; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

5.  Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.

Authors:  Benjamin R Smith; Marta B Santos; Michael S Marshall; Ludovico Cantuti-Castelvetri; Aurora Lopez-Rosas; Guannan Li; Richard van Breemen; Kumiko I Claycomb; Jose I Gallea; Maria S Celej; Stephen J Crocker; Maria I Givogri; Ernesto R Bongarzone
Journal:  J Pathol       Date:  2014-02-20       Impact factor: 7.996

6.  Synaptic failure: The achilles tendon of sphingolipidoses.

Authors:  Ludovico Cantuti-Castelvetri; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

7.  Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease.

Authors:  Carla Andreia Teixeira; Catarina Oliveira Miranda; Vera Filipe Sousa; Telma Emanuela Santos; Ana Rita Malheiro; Melani Solomon; Gustavo H Maegawa; Pedro Brites; Mónica Mendes Sousa
Journal:  Neurobiol Dis       Date:  2014-03-06       Impact factor: 5.996

8.  Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.

Authors:  Mirella Belleri; Roberto Ronca; Daniela Coltrini; Beatrice Nico; Domenico Ribatti; Pietro L Poliani; Arianna Giacomini; Patrizia Alessi; Sergio Marchesini; Marta B Santos; Ernesto R Bongarzone; Marco Presta
Journal:  Brain       Date:  2013-09       Impact factor: 13.501

9.  The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors.

Authors:  Ludovico Cantuti Castelvetri; Maria I Givogri; Amy Hebert; Benjamin Smith; Yuyu Song; Agnieszka Kaminska; Aurora Lopez-Rosas; Gerardo Morfini; Gustavo Pigino; Mark Sands; Scott T Brady; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

10.  Generation of a LacZ reporter transgenic mouse line for the stereological analysis of oligodendrocyte loss in galactosylceramidase deficiency.

Authors:  Hongling Zhu; Francesca Ornaghi; Sophie Belin; Maria I Givogri; Lawrence Wrabetz; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-07-18       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.